Medpace reduces revolving credit line to $150M, extends facility to March 2024

Medpace Holdings, Inc.

Amendment No. 5 with PNC Bank cuts the revolving credit facility from $250M to $150M.
Facility expiration extended to March 29, 2024; interest rate and fee terms adjusted.
New Amended and Restated Note executed by Medpace, Inc. (borrower); Medpace IntermediateCo remains guarantor.
Interest rate options: Base Rate plus 0.0% or Term SOFR plus 1.25% per annum for drawn amounts.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Medpace Holdings, Inc. amended Amendment No. 5 to Loan Documents with PNC Bank, National Association valued at up to $150 million (effective 2023-03-31).

Action: amendment
Agreement: credit facility
Counterparty: PNC Bank, National Association
Value: up to $150 million
Effective: 2023-03-31

Exact text from the filing

On March 31, 2023, Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No. 5 to Loan Documents (“Amendment No. 5”) with PNC Bank, National Association in connection with the Company’s unsecured credit facility (the “Loan Documents”).

View on SEC.gov

Browse all material agreements →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-23-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.